These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6460090)

  • 1. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and conjugated CSF and plasma GABA in Huntington's chorea.
    Uhlhaas S; Lange H; Wappenschmidt J; Olek K
    Acta Neurol Scand; 1986 Oct; 74(4):261-5. PubMed ID: 3028028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.
    Ferraro TN; Manyam BV; Hare TA
    J Neurochem; 1983 Oct; 41(4):1057-64. PubMed ID: 6225837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Low GABA levels in CSF in Huntington's chorea.
    Glaeser BS; Hare TA; Vogel WH; Olewiler DB; Beasley BL
    N Engl J Med; 1975 May; 292(19):1029-30. PubMed ID: 235093
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine.
    Grove J; Schechter PJ; Tell G; Rumbach L; Marescaux C; Warter JM; Koch-Weser J
    J Neurochem; 1982 Oct; 39(4):1061-5. PubMed ID: 7119781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pallidal GABA and chorea in Huntington's disease.
    Pearson SJ; Heathfield KW; Reynolds GP
    J Neural Transm Gen Sect; 1990; 81(3):241-6. PubMed ID: 2144428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.
    Welch MJ; Markham CH; Jenden DJ
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):367-74. PubMed ID: 132512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.
    Palfreyman MG; Huot S; Grove J
    Neurosci Lett; 1983 Feb; 35(2):161-6. PubMed ID: 6856194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values.
    Löscher W; Schmidt D
    Ther Drug Monit; 1984; 6(2):227-31. PubMed ID: 6740742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
    Grove J; Schechter PJ; Hanke NF; de Smet Y; Agid Y; Tell G; Koch-Weser J
    J Neurochem; 1982 Dec; 39(6):1618-22. PubMed ID: 7142991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease: biochemical prediction by determination of GABA synthesis of cultured fibroblasts.
    Göhlich G; Kuhn W; Höhn H; Przuntek H
    J Neurol; 1984; 231(1):50-1. PubMed ID: 6232351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.